Mandel-Brehm Josh
ProMIS Neurosciences, Inc. · Director
Mandel-Brehm Josh is listed in public filings as director. This Mandel-Brehm Josh insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include ProMIS Neurosciences, Inc. (PMN), and CAMP4 Therapeutics Corporation (CAMP). Investors use Mandel-Brehm Josh's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $118k11k shares | Grant / ExerciseMay 20, 2026 | $118.5K11k shares | $10.77 | -- | |
| $59k5.5k shares | Grant / ExerciseMay 20, 2026 | $59.2K5.5k shares | $10.77 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $2.6M580k shares | Grant / ExerciseApr 1, 2026 | $2.6M580k shares | $4.46 | -- | |
| $2.6M425k shares | Grant / ExerciseDec 11, 2025 | $2.6M425k shares | $6.01 | -- | |
| $459k278.4k shares | BuySep 11, 2025 | $10.0K6.1k shares | $1.65 | -- | |
| $10k20k shares | Grant / ExerciseJun 12, 2025 | $10.0K20k shares | $0.50 | -- | |
| $618k160k shares | Grant / ExerciseApr 1, 2025 | $617.6K160k shares | $3.86 | -- | |
| $44k40k shares | Grant / ExerciseOct 3, 2024 | $44.4K40k shares | $1.11 | -- |